SMMT
Summit Therapeutics Inc.
A clinical-stage biopharmaceutical company founded in 2003 in Oxford, England, that develops new medicines for serious diseases — starting with antibiotics and later shifting its focus to cancer treatments such as the lung-cancer drug ivonescimab. It went through a string of odd early names, including CobraDragon and Vastox, before settling on "Summit," a nod to reaching the peak of healthcare. Today it is listed on Nasdaq and runs offices in Miami, California, and the UK.
ADRUnderlying: SMMTCUSIP: 86627R1021 holder
Sponsored American Depositary Shares (ADS)
Total Value
$1.82M
Total Shares
175.0K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
